SEC Form 4 · accession 0001127602-18-035994
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Jul 23, 2018
Accepted (ET)
Dec 12, 2018 · 12:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 23, 2018 | G | 4,000 | $0.00 | D | 267,676 | D | |
| Common StockF1 | Aug 17, 2018 | G | 3,677 | $0.00 | D | 0 | I | 2016 GRAT |
| Common StockF2 | Dec 10, 2018 | M | 25,123 | $73.70 | A | 310,894 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $125.76 | D | 310,694 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $125.85 | D | 310,494 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $125.855 | D | 310,394 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $125.89 | D | 310,294 | D | |
| Common Stock | Dec 10, 2018 | S | 1 | $125.965 | D | 310,293 | D | |
| Common Stock | Dec 10, 2018 | S | 99 | $125.975 | D | 310,194 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $125.98 | D | 310,094 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $126.01 | D | 309,894 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.02 | D | 309,794 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.025 | D | 309,694 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.03 | D | 309,594 | D | |
| Common Stock | Dec 10, 2018 | S | 200 | $126.05 | D | 309,394 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.07 | D | 309,294 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.075 | D | 309,194 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.08 | D | 309,094 | D | |
| Common Stock | Dec 10, 2018 | S | 491 | $126.11 | D | 308,603 | D | |
| Common Stock | Dec 10, 2018 | S | 300 | $126.13 | D | 308,303 | D | |
| Common Stock | Dec 10, 2018 | S | 304 | $126.15 | D | 307,999 | D | |
| Common Stock | Dec 10, 2018 | S | 201 | $126.16 | D | 307,798 | D | |
| Common Stock | Dec 10, 2018 | S | 100 | $126.18 | D | 307,698 | D | |
| Common Stock | Dec 10, 2018 | S | 4 | $126.195 | D | 307,694 | D | |
| Common Stock | Dec 10, 2018 | S | 201 | $126.20 | D | 307,493 | D | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse | |
| Common Stock | holding | — | — | — | 18,390 | I | 2017 GRAT |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $73.70 | Dec 10, 2018 | M | 25,123 | D | Feb 26, 2017 | Feb 26, 2021 | Common Stock | 25,123 | 50,247 | D |
Explanation of responses
- F1On 8/17/2018: 6,531 shares were transferred from the 2016 GRAT to Direct Holdings.
- F2On 8/17/2018: 6,531 shares were transferred from the 2016 GRAT to Direct Holdings. On 9/08/2018: 11,564 shares were transferred from the 2017 GRAT to Direct Holdings.
- F3This sale occurred pursuant to a 10b5-1 Trading Plan.